Clin2
NCT06788444Possibly a fitRecruiting

Esketamine for irritable bowel syndrome with anxiety or depression

Irritable Bowel Syndrome

Treatments studied

Part of Digestive system clinical trials.

This study tests if esketamine, a fast-acting medication, can help people with irritable bowel syndrome who also have anxiety or depression. It is given during a colonoscopy to see if it reduces your IBS symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
552 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are between 18 and 60 years old.
  • You have been diagnosed with irritable bowel syndrome (IBS) based on Rome IV criteria.
  • You also have a diagnosis of anxiety disorder or major depression.
  • You are scheduled for a colonoscopy.
  • Your body mass index (BMI) is between 15 and 30.
  • You are in generally good physical health (ASA I or II).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06433180Not yet recruiting· Phase 3
Fecal transplant for severe irritable bowel syndrome

This trial tests whether a fecal microbiota transplantation (FMT), which transfers healthy bacteria from a donor into your gut, can reduce severe irritable bowel syndrome (IBS) symptoms. FMT is being studied as a possible new treatment for people with IBS that hasn't improved with other treatments.

Bobigny
NCT07367542Not yet recruiting
Esketamine for emotional distress during breast cancer surgery

This trial tests whether a medicine called esketamine, given during breast cancer surgery, can help reduce negative emotions like anxiety or depression before and after the operation. It may help you feel more emotionally stable during your treatment.

Beijing
NCT07002684Recruiting
Esketamine study for depression

This trial tests how treatment with esketamine affects metabolism in people with depression. It may help if you have not responded to at least two standard antidepressants.

Zagreb
NCT07374211Not yet recruiting
Esketamine for breast cancer surgery patients with severe depression

This trial tests whether a medication called esketamine, given during breast cancer surgery, can help reduce feelings of depression and anxiety after the operation. It is for women who are already experiencing severe depressive symptoms before surgery.

NCT07374198Not yet recruiting
Esketamine during breast cancer surgery to reduce depression

This study tests whether giving a medication called esketamine during breast cancer surgery can help reduce feelings of depression and anxiety after the operation. If you are having breast cancer surgery and have been feeling down, this treatment might support your emotional well-being during recovery.

NCT07002801Recruiting
Remimazolam and Esketamine for Older Adults Having Painless Stomach and Colon Scope

This trial tests a combination of two sedative medicines (Remimazolam and Esketamine) for elderly patients having a painless stomach and colon exam. The goal is to see if this combination is safe and effective for older adults.

Harbin, Heilongjiang

Hear when a new Irritable Bowel Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.